Radicava Will Be a New Specialty Med for Lou Gehrig's Disease

Radicava (ra-dih-CAH-vah, edaravone) is the first med approved for Lou Gehrig's disease, or ALS, in almost 20 years. ...

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login